Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Liabilities (2017 - 2026)

Organogenesis Holdings has reported Other Non-Current Liabilities over the past 9 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 33.45% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 33.45%, while the annual FY2025 figure was $1.2 million, 33.45% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $1.2 million at Organogenesis Holdings, down from $2.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $3.7 million in Q1 2021 and troughed at $894000.0 in Q4 2024.
  • A 5-year average of $1.5 million and a median of $1.2 million in 2023 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 88.78% in 2021 and later skyrocketed 138.33% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $1.6 million in 2021, then fell by 27.94% to $1.1 million in 2022, then grew by 8.11% to $1.2 million in 2023, then fell by 26.3% to $894000.0 in 2024, then soared by 33.45% to $1.2 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ORGO at $1.2 million in Q4 2025, $2.5 million in Q3 2025, and $3.0 million in Q2 2025.